| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.57B | -1.3% |
| R&D Expense | $307.3M | -11.8% |
| SG&A Expense | $435.5M | -6.3% |
| Operating Income | -$1.02B | -310.7% |
| Interest Expense | $23.8M | +6.8% |
| Pre-tax Income | -$993.7M | -352.5% |
| Income Tax | $7.6M | +898.9% |
| Net Income | -$1.00B | -354.4% |
| EPS (Basic) | -$5.87 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.30B | +15.5% |
| Accounts Receivable | $214.1M | -1.5% |
| Inventory | $38.1M | +29.2% |
| Current Assets | $1.66B | +11.7% |
| Total Assets | $3.52B | -19.9% |
| Current Liabilities | $941.5M | +123.8% |
| Total Liabilities | $2.03B | -2.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $293.7M | -16.1% |
| Capital Expenditures | $10.8M | -5.9% |
| Investing Cash Flow | -$124.1M | +20.7% |
| Financing Cash Flow | $8.3M | -23.4% |
| Free Cash Flow | $282.9M | -16.4% |
| -338.1% |
| EPS (Diluted) | -$5.87 | -338.1% |
| Stockholders' Equity |
| $1.49B |
| -35.9% |